DA Davidson Maintains Buy on Yext, Lowers Price Target to $16.5
DA Davidson analyst Tom White maintains Yext (NYSE:YEXT) with a Buy and lowers the price target from $18 to $16.5.
Morgan Stanley Maintains Underweight on Yext, Lowers Price Target to $12
Morgan Stanley analyst Stan Zlotsky maintains Yext (NYSE:YEXT) with a Underweight and lowers the price target from $13 to $12.
20 Stocks Moving in Friday’s Pre-Market Session
Gainers
Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 59.5% to $8.77 in pre-market trading after the company announced the ApoGraft bone marrow transplantation of the first patient in the US.
Yext Q2 EPS $(0.06) Beats $(0.07) Estimate, Sales $98.10M Beat $95.03M Estimate
Yext (NYSE:YEXT) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14.29 percent. This is a 14.29 percent increase over losses of $(0.07) per share from the same
Earnings Scheduled For September 2, 2021
Companies Reporting Before The Bell
• Navios Maritime Holdings (NYSE:NM) is projected to report earnings for its second quarter.
Yext Insights: Return On Capital Employed
Yext (NYSE:YEXT) reported Q1 sales of $91.99 million. Earnings fell to a loss of $17.23 million, resulting in a 9.98% decrease from last quarter. In Q4, Yext brought in $92.19 million in sales but lost $19.14 million in earnings.
